Short- and long-term effects of imatinib in patients hospitalised for COVID-19 infection: A randomised controlled trial
Alex L E Halme(University of Helsinki), Kari A.O. Tikkinen(Helsinki University Hospital), Marjatta Sinisalo(Tampere University Hospital), Hanna Ansakorpi(Oulu University Hospital), Aija Vanhanen(Peijas Hospital), Pauliina Kuutti(University of Helsinki), Tuomas Rosberg(University of Helsinki), Tuomas P. Kilpeläinen(University of Helsinki), Saana Horstia(University of Helsinki), Heikki Kauma(University of Oulu), Thijs Feuth(Turku University Hospital), Andreas Renner(University of Helsinki), Juuso Paajanen(Brigham and Women's Hospital), Seppo Parkkila(Tampere University), Sanna Laakkonen(University of Helsinki), Markus Perola(Broad Institute), Erja‐Leena Paukkeri(University of Helsinki), Olli Nevalainen(Tampere University), Ilkka Kalliala(Imperial College London), Jussi M. J. Mustonen(Finnish Institute of International Affairs), Maarit K. Leinonen(University of Helsinki), Hanna‐Riikka Kreivi(University of Helsinki), Taina Nykänen(Turku University Hospital), Ilari Kuitunen(University of Eastern Finland), Marjukka Myllärniemi(University of Helsinki), Petrus Järvinen(University of Helsinki), Taina Hammarén(Herttoniemi Hospital), Alvar Külmäsu(Päijät-Hämeen Keskussairaala), Riikka Ala-Karvia(Seinäjoki University of Applied Sciences), Tiina Mattila(University of Helsinki), Jarkko Mäntylä(Helsinki University Hospital), Gordon H. Guyatt(Impact), Riitta-Liisa Patovirta(University of Helsinki), Jarno Rutanen(Tampere University Hospital), Negar Pourjamal(University of Helsinki), Solidarity Finland Investigators(University of Helsinki), Riina Hankkio(Tampere University Hospital)
Cited by 0
Related Papers
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
|Nature Genetics|2008|859
Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
|PLoS Genetics|2009|661
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510